Cargando…
First report of a carbapenemase OXA-48-producing Hafnia alvei clinical isolate
INTRODUCTION. Carbapenems are usually used in the treatment of infections caused by cephalosporin-resistant Enterobacterales ; however, the increase in carbapenem-resistant Enterobacterales (CRE) has become one of the most important problems in public health. Hafnia alvei is associated with intestin...
Autores principales: | Sevillano, Laura, Herrera, Cristhian, Valdes, Álvaro, de la Hoz, Ángela, Cardeñoso, Laura, Domingo, Diego, Semiglia, Maria Auxiliadora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Microbiology Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323787/ https://www.ncbi.nlm.nih.gov/pubmed/37424558 http://dx.doi.org/10.1099/acmi.0.000498.v3 |
Ejemplares similares
-
The Molecular Weaponry Produced by the Bacterium Hafnia alvei in Foods
por: Ramos-Vivas, José, et al.
Publicado: (2022) -
To Be or Not to Be an OXA-48 Carbapenemase
por: Dabos, Laura, et al.
Publicado: (2022) -
Catheter-associated Hafnia alvei-induced Urosepsis
por: Yarlagadda, Keerthi, et al.
Publicado: (2019) -
Hafnia alvei Urosepsis in a Kidney Transplant Patient
por: Stanic, Mario, et al.
Publicado: (2015) -
Hafnia alvei: A new pathogen in open fractures
por: Litrenta, Jody, et al.
Publicado: (2017)